09/06/2022
By Mingdi Yan
Prof. Kevin Outterson, Boston University, Executive Director of CARB-X
Repairing the Broken Business Model for Antimicrobial R&D
Date: Wednesday Sept. 14, 2022, 3:30 p.m.
Virtual on Zoom: 953 7011 3908
Professor Outterson teaches health care law at Boston University, where he co-directs the Health Law Program. He serves as the founding Executive Director and Principal Investigator for CARB-X, an >$800M international public-private partnership to accelerate global antibacterial innovation. Key partners in CARB-X include the US Government (BARDA & NIAID), the Wellcome Trust, the German Federal Ministry of Education and Research (BMBF), the UK Government (GAMRIF), and the Bill & Melinda Gates Foundation. Professor Outterson’s research work focuses on the law and economics of antimicrobial resistance, particularly push and pull incentives for antimicrobials.